{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T11:03:55Z","timestamp":1786964635331,"version":"build-2736575974"},"reference-count":52,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National AIDS project","award":["F\/1230"],"award-info":[{"award-number":["F\/1230"]}]},{"name":"Center for AIDS Research at Einstein","award":["5R01HL059842"],"award-info":[{"award-number":["5R01HL059842"]}]},{"name":"Center for AIDS Research at Einstein","award":["5R01AI033774"],"award-info":[{"award-number":["5R01AI033774"]}]},{"name":"Center for AIDS Research at Einstein","award":["5R37AI033142"],"award-info":[{"award-number":["5R37AI033142"]}]},{"name":"Center for AIDS Research at Einstein","award":["5R01AI052733"],"award-info":[{"award-number":["5R01AI052733"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Opinion in Microbiology"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.mib.2012.04.004","type":"journal-article","created":{"date-parts":[[2012,5,6]],"date-time":"2012-05-06T13:10:42Z","timestamp":1336309842000},"page":"427-433","source":"Crossref","is-referenced-by-count":73,"title":["Recent progress in vaccines against fungal diseases"],"prefix":"10.1016","volume":"15","author":[{"given":"Antonio","family":"Cassone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturo","family":"Casadevall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mib.2012.04.004_bib0005","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrmicro1537","article-title":"Advances in combating fungal diseases: vaccines on the threshold","volume":"5","author":"Cutler","year":"2007","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.mib.2012.04.004_bib0010","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S1473-3099(08)70016-1","article-title":"Fungal vaccines: real progress from real challenge","volume":"8","author":"Cassone","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.mib.2012.04.004_bib0015_1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3410\/M3-13","article-title":"Vaccines for invasive fungal infections","volume":"3","author":"Spellberg","year":"2011","journal-title":"F1000 Med Rep"},{"issue":"Suppl 1","key":"10.1016\/j.mib.2012.04.004_bib0020","first-page":"S170","article-title":"Developing a vaccine against aspergillosis","volume":"49","author":"Stevens","year":"2010","journal-title":"Med Mycol"},{"key":"10.1016\/j.mib.2012.04.004_bib0025","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1567-1364.2006.00073.x","article-title":"Towards a vaccine for Cryptococcus neoformans: principles and caveats","volume":"6","author":"Datta","year":"2006","journal-title":"FEMS Yeast Res"},{"key":"10.1016\/j.mib.2012.04.004_bib0030","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/nri3085","article-title":"Vaccines for the twenty-first century society","volume":"11","author":"Rappuoli","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.mib.2012.04.004_bib0035","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0140-6736(11)60407-8","article-title":"The next decade of vaccines: societal and scientific challenges","volume":"378","author":"Moxon","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.mib.2012.04.004_bib0040","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s11908-010-0143-y","article-title":"Prospects for development of a vaccine to prevent and control vaginal candidiasis","volume":"13","author":"Fidel","year":"2011","journal-title":"Curr Infect Dis Rep"},{"key":"10.1016\/j.mib.2012.04.004_bib0045","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.4161\/hv.7.11.17821","article-title":"Candida vaccines development from point view of US patent application","volume":"7","author":"Wang","year":"2011","journal-title":"Hum Vaccine"},{"key":"10.1016\/j.mib.2012.04.004_bib0050","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1084\/jem.20030109","article-title":"Vaccine immunity to pathogenic fungi overcomes the requirement for CD4 help in exogenous antigen presentation to CD8+ T cells: implications for vaccine development in immune-deficient hosts","volume":"197","author":"Wuthrich","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.mib.2012.04.004_bib0055","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1371\/journal.ppat.0040035","article-title":"Mucosal damage and neutropenia are required for Candida albicans dissemination","volume":"4","author":"Koh","year":"2008","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.mib.2012.04.004_bib0060","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1182\/blood-2003-03-0748","article-title":"A dendritic cell vaccine against invasive aspergillosis in allogeneic hematopoietic transplantation","volume":"102","author":"Bozza","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.mib.2012.04.004_bib0065","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1177\/03946320110240S302","article-title":"Perioperative period: immunological modifications","author":"Cardinale","year":"2011","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.mib.2012.04.004_bib0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10408410903241444","article-title":"Epidemiology of invasive mycoses in North America","volume":"36","author":"Pfaller","year":"2010","journal-title":"Crit Rev Microbiol"},{"key":"10.1016\/j.mib.2012.04.004_bib0075_1","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1128\/CVI.05215-11","article-title":"Vaccine and monoclonal antibody that enhance mouse resistance to candidiasis","volume":"18","author":"Xin","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.mib.2012.04.004_bib0080_1","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1574-695X.2011.00802.x","article-title":"A highly immunogenic recombinant and truncated protein of the secreted aspartic proteases family (rSap2t) of Candida albicans as a mucosal anticandidal vaccine","volume":"62","author":"Sandini","year":"2011","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.mib.2012.04.004_bib0085","doi-asserted-by":"crossref","DOI":"10.1038\/nrd3074","article-title":"An insight into the antifungal pipeline: selected new molecules and beyond","author":"Ostrowski-Zeichner","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.mib.2012.04.004_bib0090","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1016\/j.vaccine.2010.01.012","article-title":"Beta-glucan-CRM197 conjugates as candidates antifungal vaccines","volume":"28","author":"Bromuro","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.mib.2012.04.004_bib0095","doi-asserted-by":"crossref","first-page":"13526","DOI":"10.1073\/pnas.0803195105","article-title":"Synthetic glycopeptide vaccines combining beta-mannan and peptide epitopes induce protection against candidiasis","volume":"105","author":"Xin","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.mib.2012.04.004_bib0100","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1086\/652407","article-title":"Candida albicans Hyr1p confers resistance to neutrophil killing and is a potential vaccine target","volume":"201","author":"Luo","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.mib.2012.04.004_bib0105","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1086\/504691","article-title":"Efficacy of the anti-Candida rAls3p-N or rAls1p-N vaccines against disseminated and mucosal candidiasis","volume":"194","author":"Spellberg","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.mib.2012.04.004_bib0110","doi-asserted-by":"crossref","first-page":"5075","DOI":"10.1128\/IAI.00815-06","article-title":"Vaccinations with recombinant variants of Aspergillus fumigatus allergen Asp f 3 protect mice against invasive aspergillosis","volume":"74","author":"Ito","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.mib.2012.04.004_bib0115","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1128\/CVI.00130-08","article-title":"Therapeutic efficacy of a conjugate vaccine containing a peptide mimotope of cryptococcal capsular polysaccharide glucuronoxylomannan","volume":"15","author":"Datta","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.mib.2012.04.004_bib0120","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1128\/CVI.00480-08","article-title":"Efficacy of a genetically engineered Candida albicans tet-NRG1 strain as an experimental live attenuated vaccine against hemathogeneously disseminated candidiasis","volume":"16","author":"Saville","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.mib.2012.04.004_bib0125","doi-asserted-by":"crossref","first-page":"5526","DOI":"10.1016\/j.vaccine.2011.05.030","article-title":"Immunization with the glycolytic enolase confers effective protection against Candida albicans infection in mice","volume":"29","author":"Li","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.mib.2012.04.004_bib0130","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1099\/jmm.0.033290-0","article-title":"Saccharomyces as a vaccine against systemic aspergillosis: \u2018the friend of man\u2019 a friend again?","volume":"60","author":"Liu","year":"2011","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.mib.2012.04.004_bib0135","first-page":"6","article-title":"Horizontal transmission of Candida albicans and evidence for a vaccine response in mice colonized with the fungus","author":"Cutler","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.mib.2012.04.004_bib0140","doi-asserted-by":"crossref","first-page":"11169","DOI":"10.1073\/pnas.1107941108","article-title":"Adjuvanticity of the oil-in-water emulsion MF59 is independent of Nlrp3 inflammasome but requires the adaptor protein MyD88","volume":"108","author":"Seubert","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.mib.2012.04.004_bib0145","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.vaccine.2009.10.082","article-title":"The role of Toll-like receptors and C-type lectins for vaccination against Candida albicans","volume":"28","author":"Ferwerda","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.mib.2012.04.004_bib0150","doi-asserted-by":"crossref","first-page":"5424","DOI":"10.1016\/j.vaccine.2011.05.066","article-title":"Escheriosomes mediated cytosolic delivery of Candida albicans proteins induces enhanced cytotoxic T lymphocyte response and protective immunity","volume":"29","author":"Chauban","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.mib.2012.04.004_bib0265","unstructured":"De Bernardis F, Amacker M, Aranciaa S, Sandini S, Gremionb C, Moser C, Zurbriggen R, Cassonea A: A virosomal vaccine against candidal vaginitis: immunogenicity, efficacy and safety profile in animal models. Vaccine, in press."},{"key":"10.1016\/j.mib.2012.04.004_bib0155_1","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nri2939","article-title":"Immunity to fungal infections","volume":"11","author":"Romani","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.mib.2012.04.004_bib0160_1","doi-asserted-by":"crossref","first-page":"e5392","DOI":"10.1371\/journal.pone.0005392","article-title":"Protection by anti-beta-glucan antibodies is associated with restricted beta-1,3-glucan binding specificity and inhibition of fungal growth and adherence","volume":"4","author":"Torosantucci","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.mib.2012.04.004_bib0165","doi-asserted-by":"crossref","first-page":"5085","DOI":"10.1128\/IAI.00278-07","article-title":"An anti-beta-glucan monoclonal antibody inhibits growth and capsule formation of Cryptococcus neoformans in vitro and exerts therapeutic, anticryptococcal activity in vivo","volume":"75","author":"Rachini","year":"2007","journal-title":"Infect Immun"},{"key":"10.1016\/j.mib.2012.04.004_bib0170_1","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1172\/JCI38322","article-title":"Ab binding alters gene expression in Cryptococcus neoformans and directly modulates fungal metabolism","volume":"120","author":"McClelland","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.mib.2012.04.004_bib0175_1","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1172\/JCI43984","article-title":"vaccine-induced protection against 3 systemic mycoses endemic to North America requires Th17 in mice","volume":"121","author":"Wultrich","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.mib.2012.04.004_bib0180","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1128\/IAI.05726-11","article-title":"Vaccine immunity to coccidiodomycosis occurs by early activation of three signal pathways of T helper cell responses (Th1, Th2 and Th17)","volume":"79","author":"Hung","year":"2011","journal-title":"Infect Immun"},{"key":"10.1016\/j.mib.2012.04.004_bib0185","doi-asserted-by":"crossref","first-page":"e1000703","DOI":"10.1371\/journal.ppat.1000703","article-title":"Th1\u2013Th17 cells mediate protective adaptive immunity against Staphylococcus aureus and Candida albicans infection in mice","volume":"5","author":"Lin","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.mib.2012.04.004_bib0190","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1128\/IAI.01311-10","article-title":"CD4+ T cells mediate the protective effect of the recombinant Asp f3-based anti-aspergillosis vaccine","volume":"79","author":"Diaz-Arevalo","year":"2011","journal-title":"Infect Immun"},{"key":"10.1016\/j.mib.2012.04.004_bib0195","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1002\/eji.200737409","article-title":"IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance","volume":"37","author":"Zelante","year":"2007","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.mib.2012.04.004_bib0200","doi-asserted-by":"crossref","first-page":"6611","DOI":"10.1182\/blood-2009-01-198028","article-title":"Vdelta1 T lymphocytes producing IFNg patients and IL-17 are expanded in HIV-infected and respond to Candida albicans","volume":"113","author":"Fenoglio","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.mib.2012.04.004_bib0205","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1086\/529204","article-title":"Antibody titer threshold predicts anti-candidal vaccine efficacy even though the mechanism of protection is induction of cell-mediated immunity","volume":"197","author":"Spellberg","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.mib.2012.04.004_bib0210","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1574-695X.2008.00531.x","article-title":"Immunological surrogate marker of rAls3p-N vaccine-induced protection against Staphylococcus aureus","volume":"55","author":"Lin","year":"2009","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.mib.2012.04.004_bib0215","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1084\/jem.20050749","article-title":"A novel glyco-conjugate vaccine against fungal pathogens","volume":"202","author":"Torosantucci","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.mib.2012.04.004_bib0220","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1016\/j.vaccine.2008.11.030","article-title":"Anti-beta-glucan antibodies in healthy human subjects","volume":"27","author":"Chiani","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.mib.2012.04.004_bib0225","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1038\/nm.2535","article-title":"Mechanisms of glycoconjugate vaccine activation of the adaptive immune system and its implications for vaccine design","volume":"17","author":"Auci","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.mib.2012.04.004_bib0230","doi-asserted-by":"crossref","first-page":"58815891","DOI":"10.1182\/blood-2010-12-325084","article-title":"Cross-protective TH1 immunity against Aspergillus fumigatus and Candida albicans","volume":"117","author":"Stuehler","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.mib.2012.04.004_bib0235","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1086\/599318","article-title":"IgM(+) memory B cell expression predicts HIV-associated cryptococcosis status","volume":"200","author":"Subramaniam","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.mib.2012.04.004_bib0240","first-page":"475","article-title":"Immunological reactivity of blood from healthy humans to the rAls3p-N vaccine","volume":"201","author":"Bequin","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.mib.2012.04.004_bib0245","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1086\/314546","article-title":"Evidence that members of the secretory aspartyl proteinase gene family, in particular SAP2, are virulence factors for Candida vaginitis","volume":"179","author":"De Bernardis","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.mib.2012.04.004_bib0250","doi-asserted-by":"crossref","first-page":"e22770","DOI":"10.1371\/journal.pone.0022770","article-title":"Th17 cells and IL-17 in protective immunity to vaginal candidiasis","volume":"6","author":"Pietrella","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.mib.2012.04.004_bib0255","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1086\/382882","article-title":"Vaccinate against aspergillosis! A call to arms of the immune system","volume":"38","author":"Stevens","year":"2004","journal-title":"Clin Infect Dis"}],"container-title":["Current Opinion in Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1369527412000471?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1369527412000471?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T09:11:49Z","timestamp":1561713109000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1369527412000471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S1369527412000471"],"URL":"https:\/\/doi.org\/10.1016\/j.mib.2012.04.004","relation":{},"ISSN":["1369-5274"],"issn-type":[{"value":"1369-5274","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}